Concepedia

Yu Kato

YK

Statistics

Publications

20

Citations

3.4K

H-Index

16

Active since

2001

Affiliations

Eisai (Japan)(Current)

Kyoto University

Eisai (United States)

Albert Einstein College of Medicine

Tokushima University

Yu Kato is an author at Eisai (Japan) specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2001–2021

20

Publications

20

Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma

Ryosuke Hino, Kenji Kabashima, Yu Kato et al. · Cancer · 2010 · 660 citations · Full text

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages

Takanori Kitamura, Bin‐Zhi Qian, Daniel Soong et al. · The Journal of Experimental Medicine · 2015 · 645 citations · Full text

Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway

Yu Kato, Kimiyo Tabata, Takayuki Kimura et al. · PLoS ONE · 2019 · 442 citations · Full text

, , +25

Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1‐6 hepatocellular carcinoma model

Takayuki Kimura, Yu Kato, Yoichi Ozawa et al. · Cancer Science · 2018 · 327 citations · Full text

PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice

Taku Okazaki, Il‐mi Okazaki, Jian Wang et al. · The Journal of Experimental Medicine · 2011 · 323 citations · Full text

1–5 of 20